These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 27826732
1. Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD. Abraham AG, Betoko A, Fadrowski JJ, Pierce C, Furth SL, Warady BA, Muñoz A. Pediatr Nephrol; 2017 Apr; 32(4):643-649. PubMed ID: 27826732 [Abstract] [Full Text] [Related]
2. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial. Tylicki L, Rutkowski P, Renke M, Larczyński W, Aleksandrowicz E, Lysiak-Szydlowska W, Rutkowski B. Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812 [Abstract] [Full Text] [Related]
4. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis. Onuigbo MA, Onuigbo NT. QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475 [Abstract] [Full Text] [Related]
5. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study. Voskamp PWM, Dekker FW, van Diepen M, Hoogeveen EK, PREPARE-2 Study Group. J Am Soc Hypertens; 2017 Oct; 11(10):635-643. PubMed ID: 28802945 [Abstract] [Full Text] [Related]
7. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study. Fu EL, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ. Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024 [Abstract] [Full Text] [Related]
9. Timing of patient-reported renal replacement therapy planning discussions by disease severity among children and young adults with chronic kidney disease. Ng DK, Xu Y, Hogan J, Saland JM, Greenbaum LA, Furth SL, Warady BA, Wong CS. Pediatr Nephrol; 2020 Oct; 35(10):1925-1933. PubMed ID: 32363486 [Abstract] [Full Text] [Related]
12. The outcomes of renin-angiotensin-aldosterone system inhibition and immunosuppressive therapy in children with X-linked Alport syndrome. Özdemir G, Gülhan B, Kurt-Şükür ED, Atayar E, Atan R, Dursun İ, Özçakar ZB, Saygılı S, Soylu A, Söylemezoğlu O, Yılmaz A, Bayazıt AK, Kara Eroğlu F, Kasap Demir B, Yüksel S, Tabel Y, Ağbaş A, Düzova A, Hayran M, Özaltın F, Topaloğlu R. Turk J Pediatr; 2023 Oct; 65(3):456-468. PubMed ID: 37395965 [Abstract] [Full Text] [Related]
15. Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort. Warady BA, Abraham AG, Schwartz GJ, Wong CS, Muñoz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S. Am J Kidney Dis; 2015 Jun; 65(6):878-88. PubMed ID: 25799137 [Abstract] [Full Text] [Related]
17. Is there added value to adding ARB to ACE inhibitors in the management of CKD? Cohen DL, Townsend RR. J Am Soc Nephrol; 2009 Aug; 20(8):1666-8. PubMed ID: 18776118 [Abstract] [Full Text] [Related]
19. Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis. Nistor I, De Sutter J, Drechsler C, Goldsmith D, Soler MJ, Tomson C, Wiecek A, Donciu MD, Bolignano D, Van Biesen W, Covic A. Nephrol Dial Transplant; 2018 Jan 01; 33(1):12-22. PubMed ID: 29106631 [Abstract] [Full Text] [Related]
20. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report. Weir MR, Lakkis JI, Jaar B, Rocco MV, Choi MJ, Kramer HJ, Ku E. Am J Kidney Dis; 2018 Dec 01; 72(6):873-884. PubMed ID: 30201547 [Abstract] [Full Text] [Related] Page: [Next] [New Search]